Abstract
Aim: To evaluate the impact of chronic non-cancer pain (CNCP) on healthcare useand costs among individuals diagnosed with obstructive sleep apnea (OSA). Materials&methods: Using the IQVIA PharMetrics® Plus database, we identified individuals (18-64years old) during 2007-2014, divided into two groups: OSA+CNCP versus OSA-only. Generalized linear models were used to analyze binary and count outcomes. Results: Relative to OSA-only controls, OSA+CNCP cases had increased odds for inpatient and emergency department visits and higher rates for physician office visits, non-physician outpatient visits, and prescription drug fills. Relative to controls, direct healthcare costs for cases were higher, primarily driven by inpatient and non-physician outpatient visit costs. Conclusion: Relative to OSA-only controls, OSA+CNCP cases displayed increased healthcare use and costs across all points of service.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
